ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-8.38%
↑ 54% above average
Average (3y)
-18.24%
Historical baseline
Range
High:-6.51%
Low:-49.32%
CAGR
-44.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -8.38% | +4.1% |
| 2023 | -8.74% | -34.1% |
| 2022 | -6.51% | +86.8% |
| 2021 | -49.32% | - |